increased glutathione in acute myeloid leukemia Targeting Aberrant Metabolism to Eradicate Human Myelogenous Cells* Emerging role of glutathione peroxidase
Description
E.SullivanA
In a meta-analysis of reports from 2000 to 2020 [156], the 10-year recurrence-free survival rate was 80% (95%CI 7089%) and the 10-year cumulative OS rate was 76% (95%CI 7082%)
Combined supplementation with Glycine and tryptophan reduces purine-induced serum uric acid elevation by accelerating urinary uric acid excretion: a randomized, single-blind, placebo-controlled, crossover study
Drugs targeting IL-12/IL-23 are currently in intensive clinical development, with guselkumab and mirikizumab being the most frequently mentioned [69]
Antipsychotic dose equivalents and dose-years: a standardized method for comparing exposure to different drugs
Furthermore, this same study described that -KG produced from glutaminolysis promotes LPS-induced endotoxin tolerance 36
